07:00 , Aug 24, 2015 |  BC Week In Review  |  Clinical News

Kadimastem preclinical data

In a rat model of ALS, Kadimastem’s hESC-derived astrocyte precursor cells injected into the spinal fluid significantly improved life expectancy and motor abilities vs. untreated controls. Kadimastem Ltd. (Tel Aviv:KDST), Ness Ziona, Israel   Product:...